Transport of fluorescent bile acids by the isolated perfused rat liver: kinetics, sequestration, and mobilization. 1998

F Holzinger, and C D Schteingart, and H T Ton-Nu, and C Cerrè, and J H Steinbach, and H Z Yeh, and A F Hofmann
Department of Medicine, University of California, San Diego, La Jolla 92093-0813, USA.

Hepatocyte transport of six fluorescent bile acids containing nitrobenzoxadiazolyl (NBD) or a fluorescein derivative on the side chain was compared with that of natural bile acids using the single-pass perfused rat liver. Compounds were infused at 40 nmol/g liver min for 15 minutes; hepatic uptake and biliary recovery were measured; fractional extraction, intrinsic basolateral clearance, and sequestration (nonrecovery after 45 minutes of additional perfusion) were calculated. Fluorescent bile acids were efficiently extracted during the first 3 minutes (70%-97%), but net extraction decreased with time mostly because of regurgitation into the perfusate. For cholylglycine and ursodeoxycholylglycine (UDC-glycine), extraction was 94% to 99%, and regurgitation did not occur. Intrinsic hepatic clearance of fluorescent bile acids (2-7 mL/g liver x min) was lower than that of cholylglycine (9.0 +/- 0.6; mean +/- SD) and UDC-glycine (21.4 +/- 0.4). Sequestration at 60 minutes was 8% to 26% for fluorescent bile acids with a cholyl moiety (cholylglycylaminofluorescein [CGamF], cholyllysylfluorescein [C-L-F], cholyl-[N epsilon-NBD]-lysine [C-L-NBD], and cholylaminofluorescein [CamF]), 32% for ursodeoxycholylaminofluorescein (UDCamF), and 88% for ursodeoxycholyl-(N epsilon-NBD)lysine (UDC-L-NBD). Cholylglycine and UDC-glycine had <3% retention. Biliary secretion of sequestered UDCamF, but not of UDC-L-NBD, was induced by adding dibutyryl cyclic adenosine monophosphate (DBcAMP) to the perfusate, possibly by translocation to the canaliculus of pericanalicular vesicles containing fluorescent bile acids. Biliary secretion of UDC-L-NBD, but not of UDCamF, was induced by adding cholyltaurine or UDC-taurine, possibly by inhibition of binding to intracellular constituents or of transport into organelles. It is concluded that fluorescent bile acids are efficiently transported across the basolateral membrane, but in contrast to natural conjugated bile acids, are sequestered in the hepatocyte (UDC derivatives > cholyl derivatives). Two modes of hepatic sequestration of fluorescent bile acids were identified. Fluorescent bile acids may be useful to characterize sequestration processes during bile acid transport through the hepatocyte.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D003994 Bucladesine A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed) Dibutyryl Adenosine-3',5'-Monophosphate,Dibutyryl Cyclic AMP,(But)(2) cAMP,Bucladesine, Barium (1:1) Salt,Bucladesine, Disodium Salt,Bucladesine, Monosodium Salt,Bucladesine, Sodium Salt,DBcAMP,Dibutyryl Adenosine 3,5 Monophosphate,N',O'-Dibutyryl-cAMP,N(6),0(2')-Dibutyryl Cyclic AMP,AMP, Dibutyryl Cyclic,Adenosine-3',5'-Monophosphate, Dibutyryl,Cyclic AMP, Dibutyryl,Dibutyryl Adenosine 3',5' Monophosphate,Disodium Salt Bucladesine,Monosodium Salt Bucladesine,N',O' Dibutyryl cAMP,Sodium Salt Bucladesine
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

F Holzinger, and C D Schteingart, and H T Ton-Nu, and C Cerrè, and J H Steinbach, and H Z Yeh, and A F Hofmann
January 1988, Biochemical pharmacology,
F Holzinger, and C D Schteingart, and H T Ton-Nu, and C Cerrè, and J H Steinbach, and H Z Yeh, and A F Hofmann
December 1976, Toxicology and applied pharmacology,
F Holzinger, and C D Schteingart, and H T Ton-Nu, and C Cerrè, and J H Steinbach, and H Z Yeh, and A F Hofmann
September 1976, The American journal of physiology,
F Holzinger, and C D Schteingart, and H T Ton-Nu, and C Cerrè, and J H Steinbach, and H Z Yeh, and A F Hofmann
March 1997, Pharmacology & toxicology,
F Holzinger, and C D Schteingart, and H T Ton-Nu, and C Cerrè, and J H Steinbach, and H Z Yeh, and A F Hofmann
January 1960, Comptes rendus des seances de la Societe de biologie et de ses filiales,
F Holzinger, and C D Schteingart, and H T Ton-Nu, and C Cerrè, and J H Steinbach, and H Z Yeh, and A F Hofmann
February 1961, Comptes rendus hebdomadaires des seances de l'Academie des sciences,
F Holzinger, and C D Schteingart, and H T Ton-Nu, and C Cerrè, and J H Steinbach, and H Z Yeh, and A F Hofmann
September 1982, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
F Holzinger, and C D Schteingart, and H T Ton-Nu, and C Cerrè, and J H Steinbach, and H Z Yeh, and A F Hofmann
March 1972, Canadian journal of physiology and pharmacology,
F Holzinger, and C D Schteingart, and H T Ton-Nu, and C Cerrè, and J H Steinbach, and H Z Yeh, and A F Hofmann
May 1999, Journal of hepatology,
F Holzinger, and C D Schteingart, and H T Ton-Nu, and C Cerrè, and J H Steinbach, and H Z Yeh, and A F Hofmann
February 1994, The American journal of physiology,
Copied contents to your clipboard!